Introduction {#Sec1}
============

*Chlamydia trachomatis (C. trachomatis)* is a major sexually transmitted bacterial pathogen \[[@CR1]\]. Since chlamydial infections are usually asymptomatic or oligosymptomatic, they are difficult to diagnose and may thus lead to serious sequels. One of the complications of *C. trachomatis* infection in men is chronic prostatitis \[[@CR15], [@CR22], [@CR24]\]. The concentration of citric acid, which is produced and stored in the prostate in great amounts, can be regarded as an indicator of the normal functioning of the prostate \[[@CR2], [@CR6]\]. When the function is impaired, e.g. due to prostatitis, the concentration of citric acid is reduced \[[@CR2], [@CR7]\].

The aim of this study was to evaluate the correlation between the presence of anti-*C. trachomatis* antibodies in the serum and prostatic secretion and the concentration of citric acid in patients with chronic prostatitis.

Materials and Methods {#Sec2}
=====================

The study involved 34 men aged 18--65 years (mean: 38 years) with chronic prostatitis referred to the Center for Sexually Transmitted Disease Research and Diagnostics in Białystok by urological consulting units. These patients belonged to group III according to the National Institutes of Health (NIH) prostatitis classifipain syndrome \[[@CR15]\]. None of the patients had been treated with antibiotics for at least three months before the study.

Expressed prostatic secretions (EPS) and blood serum were used as the material for analysis. The polymorphonuclear leukocyte (PMN) count, the presence of anti-*C. trachomatis* antibodies (IgA and IgG), and citric acid concentration were determined in the prostatic secretion. The serum was examined for IgM, IgA, and IgG class anti-*C. trachomatis* antibodies.

A drop of EPS was used to make a direct preparation on a glass slide. After fixation and staining by means of Gram\'s method, leukocytes were counted. Inflammation of the prostate was diagnosed when the PMN count was \>-10 in the visual field under a light microscope with a magnification of ×1000.

The anti-*C. trachomatis* antibodies were determined using the immunoenzymatic method. Specific IgG antibodies were identified in the serum by means of *Chlamydia* IgG EIA (Labsystem, Finland) and serum IgM+IgA and IgG+IgA in the EPS with *Chlamydia* rELISA (Medac, Germany). In the tests performed using the Labsystem kit, according to the manufacturer\'s instructions a value of ≥20 enzyme immunoassay unit (EIU) was considered positive (\<10 EIU: negative, 10--19 EIU: equivocal, 20--59 EIU: weakly positive, 60--110 EIU: positive, \>110 EIU: strongly positive). With the Medac kit, titers equal to or greater than 1:100 (IgG antibodies) and 1:50 (IgM and IgA antibodies) were treated as positive.

The concentration of citric acid was determined at the Department of Medical Biochemistry, Medical University of Bia3ystok, using the ultraviolet method (TC Citric Acid, Boehringer, Germany) \[[@CR23]\]. A concentration of 18.84±0.72 mg/ml (18.12--19.59 mg/ml) was treated as normal \[[@CR5]\].

This study was approved by the University Ethics Committee.

Results {#Sec3}
=======

Inflammation of the prostate was found in 21/34 (61.8%) patients. A reduction in citric acid concentration in the prostatic secretion was detected in 20/34 (58.8%) men. In most patients (17/20, 85%), the reduced citric acid concentration was accompanied by an elevated PMN count in the EPS (\>-10/vision field).

Specific serum antibodies were detected in 20/34 (58.8%) patients, including IgM in 8/34 (23.5%), IgA in 11/34 (32.4%), and IgG in 15/34 (44.1%; Fig. [1](#Fig1){ref-type="fig"}). All the patients showed low titers of IgM and IgA antibodies in the serum and 7/15 (46.7%) patients had strongly positive IgG antibodies. In 11/15 (73.3%) patients, the specific IgG antibodies in the serum occurred together with IgM and/or IgA antibodies, and were found isolated in the remaining 4/15 (26.7%) cases. Table [1](#Tab1){ref-type="table"} presents a list of positive serological outcomes according to the immunoglobulin classes. The synergistic occurrence of IgG and IgA was the most common (35%), the isolated occurrence of IgG antibodies was less common (20%), and of IgA the least common (5%). Fig. 1The rate of detection of anti-*C. trachomatis* antibodies in the serum in chronic prostatitis patients.Table 1Co-occurrence of anti-*C. trachomatis* antibodies according to immunoglobulin class in a group of 20 patients with serum-positive serological outcomesClass of immunoglobulin anti-*C. trachomatis* antibodies in serumPatients with serum-positive serological outcomes (N=20)n%IgM210IgA15IgG420IgG+IgM210IgG+IgA735IgM+IgA210IgG+IgM+IgA210Total20100

The anti-*C. trachomatis* antibodies in the EPS were detected in 15/34 (44.1%) patients, including 11/34 (32.4%) with IgA and 12/34 (35.3%) with IgG (Fig. [2](#Fig2){ref-type="fig"}). In contrast to serum, the titers of IgG antibodies in the EPS were low in all the patients, while those of IgA were strongly positive in 6/11 (54.5%) patients. Table [2](#Tab2){ref-type="table"} presents the serum antibodies of the respective classes in the EPS. The co-occurrence of IgA and IgG (53.3%) was the most frequent, isolated IgG antibodies were less common (26.7%), and isolated class IgA the least common (20%). Fig. 2The rate of detection of anti-*C. trachomatis* antibodies in the EPS in chronic prostatitis.Table 2Co-occurrence of anti-*C. trachomatis* antibodies according to immunoglobulin class in a group of 15 patients with EPS-positive serological outcomesClass of immunoglobulin anti-*C. trachomatis* antibodies in the EPSPatients with EPS-positive serological outcomes (N=15)n%IgA320IgG426.7IgG+IgA853.3Total15100

In the group of 20 patients with positive serum and/or EPS outcomes, 17 (85%) had reduced concentrations of citric acid (Table [3](#Tab3){ref-type="table"}). In the majority of patients with reduced citric acid concentration in the EPS (16/17, 94.1%), anti-*C. trachomatis* antibodies were present both in the serum and EPS. The greatest decline in the concentration of citric acid was observed in men showing remarkably high titers of IgA antibodies in the EPS and/or IgG in the serum. Table 3Correlation of occurrence of anti-*C. trachomatis* antibodies in serum or/and EPS with citric acid concentration in the prostatic secretionConcentration of citric acid in EPSPatients with positive serological outcomes (N=20)Total (%)only in EPS n (%)only in serum n (%)in EPS and in serum n (%)Decreased01 (5)16 (80)17 (85)No changes03 (15)03 (15)Total04 (20)16 (80)20 (100)

Discussion {#Sec4}
==========

Prostatitis, a major sequel of *C. trachomatis* urethritis in men, is usually chronic and oligosymptomatic \[[@CR17]\]. The bacteriological diagnostics of prostatitis is very difficult, mainly due to the poor availability of adequate material and the difficult choice of a proper method \[[@CR21]\]. Fundamental methods in diagnosing chlamydial infections are direct methods that detect bacterial antigens (DIF, i.e. the direct immunfluorescence test, and EIA), genetic material (PCR, i.e. polymerase chain reaction, LCR, i.e. ligase chain reaction), or, currently rarely performed, culture methods. The role of serodiagnostics using both serum and prostatic secretion has been emphasized in literature, especially because of the non-invasive nature of the method and the easy availability of the material \[[@CR18]\]. There are only a few studies concerning the problem of chlamydial prostatitis combined with determining citric acid concentration.

In our study, serum IgG antibodies were the most frequently detected (44.1%), IgA antibodies were less, and IgM the least common (32.4% and 23.5%, respectively). In all cases the titers of IgA and IgM antibodies were low, while those of IgG were high in nearly half of the patients (46.7%). Similar or higher values of IgG antibodies were noted by Weidner et al. \[[@CR20]\] (40.5%) and Peeters et al. \[[@CR16]\] (49%), but lower were reported by Kojima et al. \[[@CR9]\] (7.5%) and Miyata et al. \[[@CR14]\] (29%). High titers of specific IgG antibodies as well as the presence of IgA antibodies in the serum provide evidence for an active, *Chlamydia*-induced pathological process. The role of IgM antibodies in the diagnostics of chronic prostatitis is slight, as they can be detected only in the very early phase of infection and are thus rarely found in men with chronic prostatitis \[[@CR4], [@CR12]\].

We found specific IgG antibodies in the prostatic secretion in 35.3% of the men and IgA in 32.4%. Contrary to the serum, the values of IgA antibodies in the EPS were considerably higher than the titers of IgG antibodies. In all the patients, the presence of specific antibodies in the EPS was accompanied by anti-*C. trachomatis* antibodies in the serum and elevated EPS leukocyte count. Similar results concerning IgA antibodies were reported by Japanese authors, who found them in the prostatic secretion in 31.5% \[[@CR13]\] and 29% \[[@CR10]\] of men. High titers of IgA antibodies and increased PMN counts detected in the EPS indicate stimulation of the local immunological response by resident microorganisms. Tsunekawa et al. \[[@CR18], [@CR19]\] also observed high titers of IgA and low titers of IgG in the EPS compared with serum. Ludwig et al. \[[@CR11]\] considered the determination of anti-*C. trachomatis* antibodies in serum unserviceable in diagnosing chlamydial infection, while the role of antibodies in semen, especially the IgA class, is still unclear and needs further investigation. The authors revealed in their study significant correlation only between seminal plasma antibodies against *C. trachomatis* and positive PCR results in the ejaculate. In our study, the level of IgA antibodies in the EPS was particularly high, in contrast to the serum level.

The role of antichlamydial antibodies in *C. trachomatis* infection is still controversial. However, it is still believed that antibody marking may be important in detecting the spread of chronic urogenital tract infections on the ascending path from the urethra or cervix and its remote complications, such as epididymitis, prostatitis, pelvic inflammatory disease, or infertility.

In most patients (85%) with specific antibodies detected in the serum or/and EPS there was a simultaneous decrease in the concentration of citric acid in the prostatic secretion. The prostate is the major site of production and the largest reservoir of citric acid in the organism \[[@CR3], [@CR6]\]. The level of citric acid decreases in inflammatory conditions of the prostate and in other diseases that impair the functioning of the gland \[[@CR2], [@CR8]\]. A reduced concentration of citric acid in patients with detected infection of *C. trachomatis* suggests the existence of prostatitis induced by *Chlamydia*. In an earlier study we conducted research in the same group of patients evaluating the relationship between chlamydial prostatitis detected by means of direct tests (DIF, PCR) and citric acid concentration in the prostate gland \[[@CR25]\]. We found that chlamydial infection of the prostate coexisted in all cases with a reduced concentration of citric acid, in most of the cases significantly. No literature reports are available on the relationship between the detection of anti-*C. trachomatis* antibodies in the serum and/or EPS and the concentration of citric acid in the EPS.

In conclusion, 1) the occurrence of anti-*C. trachomatis* antibodies in the serum and/or EPS in most patients is accompanied by a decrease in the concentration of citric acid in the prostatic secretion, suggesting functional impairment of the gland; 2) serological investigations of the serum and EPS for chlamydial infection can be treated as a supplementary, non-invasive method in the diagnostics of chronic prostatitis.
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